珠江股份(600684.SH)拟出售股票资产预计收益超去年净利润50%

Core Viewpoint - The company plans to sell a total of 8.686 million shares of Yibai Pharmaceutical, 970,600 shares of Aorui De, 7,716 shares of China Ping An, and 4.7122 million shares of Erkang Pharmaceutical based on market conditions, with the transaction details remaining uncertain [1] Summary by Category - Planned Share Sales - The company intends to sell shares of multiple companies, including Yibai Pharmaceutical, Aorui De, China Ping An, and Erkang Pharmaceutical [1] - Financial Impact - The estimated proceeds from the sale, after deducting holding costs and related taxes, are expected to account for over 50% of the company's audited net profit for the last year [1] - Approval Requirement - The proposed sale is subject to approval by the shareholders' meeting, indicating that finalization of the transaction is contingent upon shareholder consent [1]